Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ingrid Filgaira
Observed name:
I. Filgaira
Institutions:
Institut d'Investigació Biomédica de Bellvitge,
Universitat de Barcelona
Observed institutions:
Bellvitge University Hospital,
Institut d'Investigació Biomédica de Bellvitge,
Universitat de Barcelona
ORCID:
0000-0002-9886-3925
Observed ORCID:
0000-0002-9886-3925
OpenAlex ID:
A5064824742
Riluzole-Loaded Nanostructured Lipid Carriers for Hyperproliferative Skin Diseases
2023
·
Xavier Llorente
, Gerard Esteruelas
, et al.
·
International Journal of Molecular Sciences
·
32
PDF
Optical control of adenosine A3 receptor function in psoriasis
2021
·
Marc López-Cano
, Ingrid Filgaira
, et al.
·
Pharmacological Research
·
26
Photoswitchable Diazocine Derivative for Adenosine A 3 Receptor Activation in Psoriasis
2024
·
Marc López-Cano
, Mirko Scortichini
, et al.
·
Journal of the American Chemical Society
·
25
PDF
Single loss of a Trp53 allele triggers an increased oxidative, DNA damage and cytokine inflammatory responses through deregulation of IκBα expression
2021
·
Laura Marruecos
, Joan Manils
, et al.
·
Cell Death and Disease
·
7
PDF
Bioinformatic analysis of molecular characteristics and oncogenic features of CARD14 in human cancer
2024
·
Daniil Bespalov
, Dayana Pino
, et al.
·
Scientific Reports
·
2
PDF
343 TREX2 inhibitors: a breakthrough keratinocyte-based therapy for psoriasis
2024
·
I. Filgaira
, S. Piticchio
, et al.
·
Journal of Investigative Dermatology
·
1
Show more works
View as search
Works count:
6
Citation count:
93
H-index:
4
I10-index:
3
Year
Topic
Type